Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | BACE1 | P56817 | 6/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CTSD | P07339 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7268683 | 0.92 | CTSD (0.65) | ALDH1A1BACE1CA2CTSD | |
| SCHEMBL7269992 | 0.89 | CTSD (0.61) | BACE1CA2CTSDL3MBTL1 | |
| SCHEMBL7270439 | 0.84 | CA2 (0.68) | ALDH1A1BACE1CA2CTSD | |
| SCHEMBL7269055 | 0.83 | CA2 (0.52) | BACE1CA2CTSDLMNANAMPT | |
| SCHEMBL6446529 | 0.83 | LMNA (0.56) | BACE1CA2CTSDLMNAKMT2A | |
| SCHEMBL7270066 | 0.83 | CA2 (0.56) | BACE1CA2CTSDLMNA | |
| SCHEMBL7268971 | 0.82 | CTSD (0.63) | CA2CTSD | |
| SCHEMBL6446176 | 0.82 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1PKMKMT2A | |
| SCHEMBL6446181 | 0.82 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1PKMKMT2A | |
| SCHEMBL7275770 | 0.82 | CTSD (0.65) | CA2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0402646-B1 | Retroviral protease inhibiting compounds | ABBOTT LAB (US) | 1998-07-22 | — | — | EP | disclosed |
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |